GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Daewoong Pharmaceutical Co Ltd (XKRX:069620) » Definitions » Net Interest Income (for Banks)

Daewoong Pharmaceutical Co (XKRX:069620) Net Interest Income (for Banks)


View and export this data going back to 2002. Start your Free Trial

What is Daewoong Pharmaceutical Co Net Interest Income (for Banks)?

Net Interest Income only applies to banks.


Daewoong Pharmaceutical Co Business Description

Traded in Other Exchanges
N/A
Address
12, Bongeunsa-ro 114-gil, Daewoong Pharmaceutical Building, Gangnam-gu, Seoul, KOR
Daewoong Pharmaceutical Co Ltd develops, manufactures and sells prescription drug products. The company's product portfolio comprises products such as Moxicle, Plunazol Cap, Bearcef tab, Newdizime etc. It develops and promotes brands such as Ursa, Nabota, Luphere, Easyef, Cretropin. The company has manufacturing facilities at Hyangnam and Sungnam.